[Tag] [Tag] [Tag] [Tag] [Tag] [Tag] [Tag] [Tag] [Tag] [Tag] [Tag] [Tag] [Tag] [Tag] precisely right. My point is that either we ask for cancer drugs that improve outcomes that matter, or we let patients take personal risk
But it is a strange system that says 12% RR is ok for nivo in small cell, but 6.7% is not ok for TMB-
There is no logical cutpoint of RR